Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$33.34 -0.07 (-0.21%)
At close: Nov 11, 2026 · 4:00 PM EST

Lakefront Biotherapeutics (LKFT) Other Accumulated Expenses (2014)

Updated

Lakefront Biotherapeutics' Other Accumulated Expenses came in at -$3.24 million for the quarter ended Mar 31, 2026, compared with -$4.39 million a year earlier.

Analysis

Lakefront Biotherapeutics (LKFT) Other Accumulated Expenses (2014) Analysis & Trends

As of Dec 31, 2023, Lakefront Biotherapeutics' Other Accumulated Expenses was -$6.11 billion.

  • Going back by year, Other Accumulated Expenses was -$155.52 million in the year ended Dec 31, 2022, -$82.79 million in the year ended Dec 31, 2021, -$75.89 million in the year ended Dec 31, 2020 and -$581.78 million in the year ended Dec 31, 2019.
  • The five-year range for quarterly Other Accumulated Expenses is -$6.11 billion (the quarter ended Dec 31, 2023) to -$665,592 (the quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Lakefront Biotherapeutics 2.20 Bn 2.20 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 1, 2014 -7.25 Mn
API Access

Lakefront Biotherapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LKFT&period=max&api_key=YOUR_API_KEY